Warren Buffett diagnosed with cancer: “Not remotely life threatening”


Warren Buffett, the legendary investor and chairman and CEO of Berkshire Hathaway (NYSE: BRK-A  ) (NYSE: BRK-B  ), announced today that he has stage 1 prostate cancer. (Read Buffett’s letter here).

Buffett, 81, describes his condition as “not remotely life threatening or even debilitating in any meaningful way.” Buffett’s doctors discovered signs of the condition during a routine checkup; they have decided on a 60-day treatment program of daily radiation.

Buffett says that while the treatments will restrict his travel, they will not otherwise affect his daily routine. Presumably, this means that Buffett still intends to participate in Berkshire’s upcoming annual meeting, which is attended by tens of thousands and widely lauded as “Woodstock for Capitalists.” The jarring news sent shares of Berkshire down around 2% in after-hours trading.

Motley Fool Share Advisor Investment Analyst Dean Morel says…

Prostate cancer is seldom a killer in old men and is very common. The saying goes, you die with prostate cancer, not from it.

Related Warren Buffett content

The Motley Fool’s purpose is to help the world invest, better. Take Stock is The Motley Fool’s free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. Click here now to request your free subscription, whilst it’s still available.

This article was originally written by Joe Magyer, and published on fool.com. It has been updated.

OUR #1 DIVIDEND PICK FOR 2016...

Forget BHP and Woolworths. This "dirt cheap" company is growing like gangbusters, and trading on a 5.6% dividend yield, FULLY FRANKED (8% gross). With interest rates set to stay at these low levels for years to come, for hungry investors, including SMSFs, this ASX company could be the "holy grail" of dividend plays for 2016.

Enter your email below to discover the name, code and a full investment analysis in our brand-new FREE report, “The Motley Fool’s Top Dividend Stock for 2016.”

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our https://www.fool.com.au/financial-services-guide">Financial Services Guide (FSG) for more information.